Clinical Trial

The Effects of Cannabis on Post Operative Recovery After Radical Cystectomy

Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
This will be an open-label, single group supportive care pilot study in which patients are given cannabinoid gummies in the perioperative setting to alleviate RC/UD symptoms and improve quality of life. The primary objective will be to evaluate the safety and tolerability of a cannabigerol supplement used perioperatively (from 14 days prior to surgery to 30 days following surgery) by patients undergoing radical cystectomy with urinary diversion (RC/UD).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-04.
Trial Details
NCT Number NCT07577999
Lead Sponsor Stanford University
Conditions Non-metastatic Bladder Cancer
Enrollment 20 participants
Start Date 2027-07
Primary Completion 2028-05 (estimated)
Study Completion 2028-05 (estimated)
Updated on ClinicalTrials.gov 2026-07-23